Article Data

  • Views 457
  • Dowloads 151


Open Access

Evidence-based circumcision policy for Australia

  • Brian J. Morris1,*,
  • Athos Katelaris2
  • Norman J. Blumenthal3
  • Mohamed Hajoona4
  • Adrian C. Sheen5
  • Leslie Schrieber6
  • Eugenie R. Lumbers7
  • Alex D. Wodak8
  • Phillip Katelaris9

1School of Medical Sciences, University of Sydney, Sydney, NSW 2006, Australia

2Department of Urology, St George Hospital, Sydney, NSW 2217, Australia

3Department of Obstetrics and Gynaecology, SAN Clinic, Wahroonga, NSW 2076, Australia

4Victoria Circumcision Clinic, The Regent Medical Group, Preston, VIC 3072, Australia

5 Mulgoa Medical Centre, Mulgoa, NSW 2745, Australia

6Department of Medicine, Royal North Shore Hospital, St Leonards, NSW 2065, Australia

7School of Biomedical Sciences and Pharmacy, University of Newcastle, Pregnancy and Reproduction Program, Hunter Medical Research Institute, New Lambton Heights

8 Priority Research Centre for Reproductive Sciences, University of Newcastle, Callaghan, NSW 2308, Australia

9St Vincent's Hospital, Australian Tobacco Harm Reduction Association and Australia21, Darlinghurst, NSW 2010, Australia

10 Katelaris Urology, North Shore Private Hospital, St Leonards, NSW 2065, Australia

DOI: 10.31083/j.jomh1806132 Vol.18,Issue 6,June 2022 pp.1-20

Published: 30 June 2022

*Corresponding Author(s): Brian J. Morris E-mail:


The aim was (1) to perform an up-to-date systematic review of the male circumcision (MC) literature and (2) to determine the number of adverse medical conditions prevented by early MC in Australia. Searches of PubMed using “circumcision” with 39 keywords and bibliography searches yielded 278 publications meeting our inclusion criteria. Early MC provides immediate and lifetime benefits, including protection against: urinary tract infections, phimosis, inflammatory skin conditions, inferior penile hygiene, candidiasis, various STIs, and penile and prostate cancer. In female partners MC reduces risk of STIs and cervical cancer. A risk-benefit analysis found benefits exceeded procedural risks, which are predominantly minor, by approximately 200 to 1. It was estimated that more than 1 in 2 uncircumcised males will experience an adverse foreskin-related medical condition over their lifetime. An increase in early MC in Australia to mid-1950s prevalence of 85% from the current level of 18.75% would avoid 77,000 cases of infections and other adverse medical conditions over the lifetime for each annual birth cohort. Survey data, physiological measurements, and the anatomical location of penile sensory receptors responsible for sexual sensation indicate that MC has no detrimental effect on sexual function, sensitivity or pleasure. US studies found that early infant MC is cost saving. Evidence-based reviews by the AAP and CDC support early MC as a desirable public health measure. Although MC can be performed at any age, early MC maximizes benefits and minimises procedural risks. Parents should routinely be provided with accurate, up-to-date evidence-based information in an unbiased manner early in a pregnancy so that they have time to weigh benefits and risks of early MC and make an informed decision should they have a son. Parental choice should be respected. A well-trained competent practitioner is essential and local anaesthesia should be routinely used. Third party coverage of costs is advocated.


circumcision male; policy; urinary tract infection; sexually transmitted infections; inflammatory conditions; penile cancer;

prostate cancer; sexual function; complications; risk benefit; cost benefit

Cite and Share

Brian J. Morris,Athos Katelaris,Norman J. Blumenthal,Mohamed Hajoona,Adrian C. Sheen,Leslie Schrieber,Eugenie R. Lumbers,Alex D. Wodak,Phillip Katelaris. Evidence-based circumcision policy for Australia. Journal of Men's Health. 2022. 18(6);1-20.


[1] Cox G, Morris BJ. Why circumcision: from prehistory to the twenty-first century. Surgical Guide to Circumcision. 2012; 59: 243–259.

[2] World Health Organization and Joint United Nations Pro-gram on HIV/AIDS. Male circumcision: Global trends and determinants of prevalence, safety and acceptability. 2007. Available at: 9789241596169_eng.pdf (Accessed: 25 October 2021).

[3] World Health Organization and UNAIDS. New data on male cir-cumcision and HIV prevention: policy and programme implica-tions. 2007. Available at: commendations_en.pdf (Accessed: 25 October 2021).

[4] World Health Organization. Remarkable progress in the scale up of voluntary medical male circumcision as an HIV prevention intervention in 15 ESA countries: UNAIDS and WHO, 2019. Available at: medical-male-circumcision-progress-brief-2019 (Accessed: 28 October 2021).

[5] Borgdorff MW, Kwaro D, Obor D, Otieno G, Kamire V, Odongo F, et al. HIV incidence in western Kenya during scale-up of an-tiretroviral therapy and voluntary medical male circumcision: A population-based cohort analysis. The Lancet HIV. 2018; 5: e241–e249.

[6] Morris BJ, Wamai RG, Henebeng EB, Tobian AA, Klausner JD, Banerjee J, et al. Estimation of country-specific and global prevalence of male circumcision. Population Health Metrics. 2016; 14: 4.

[7] Ferris JA, Richters J, Pitts MK, Shelley JM, Simpson JM, Ryall R, et al. Circumcision in Australia: further evidence on its effects on sexual health and wellbeing. Australian and New Zealand Journal of Public Health. 2010; 34: 160–164.

[8] Qin KR, Paynter JA, Wang LC, Mollah T, Qu LG. Early child-hood circumcision in Australia: trends over 20 years and inter-rupted time series analysis. ANZ Journal of Surgery. 2021; 91: 1491–1496.

[9] Introcaso CE, Xu F, Kilmarx PH, Zaidi A, Markowitz LE. Preva-lence of circumcision among men and boys aged 14 to 59 years in the United States, National Health and Nutrition Examination Surveys 2005–2010. Sexually Transmitted Diseases. 2013; 40: 521–525.

[10] Blank S, Brady M, Buerk E, Carlo W, Diekema D, Freedman A, et al. Circumcision policy statement. Pediatrics. 2012; 130: 585–586.

[11] Blank S, Brady M, Buerk E, Carlo W, Diekema D, Freedman A, et al. Male circumcision. Pediatrics. 2012; 130: e756–e785.

[12] Centers for Disease Control and Prevention. Information for providers counseling male patients and parents regarding male circumcision and the prevention of HIV infection, STIs, and other health outcomes. 2018. Available at: https://stacks.cdc.g ov/view/cdc/58456 (Accessed: 25 October 2021).

[13] Centers for Disease Control and Prevention. Background, Meth-ods, and Synthesis of Scientific Information Used to Inform “In-formation for Providers to Share with Male Patients and Par-ents Regarding Male Circumcision and the Prevention of HIV Infection, Sexually Transmitted Infections, and other Health Outcomes”. 2018. Available at: c/58457 (Accessed: 25 October 2021).

[14] Morris BJ, Wodak AD, Mindel A, Schrieber L, Duggan KA, Dil-ley A, et al. Infant male circumcision: an evidence-based policy statement. Open Journal of Preventive Medicine. 2012; 02: 79–92.

[15] Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. British Medical Journal. 2001; 323: 334–336.

[16] Dave S, Afshar K, Braga LH, Anderson P. Canadian Urologi-cal Association guideline on the care of the normal foreskin and neonatal circumcision in Canadian infants (full version). Cana-dian Urological Association Journal. 2018; 12: E76–E99.

[17] Gairdner D. The fate of the foreskin, a study of circumcision. British Medical Journal. 1949; 2: 1433–1437.

[18] Morris BJ, Matthews JG, Krieger JN. Prevalence of phimosis in males of all ages: systematic review. Urology. 2020; 135: 124–132.

[19] Morris BJ, Krieger JN. Penile inflammatory skin disorders and the preventive role of circumcision. International Journal of Pre-ventive Medicine. 2017; 8: 32.

[20] Morris BJ, Waskett JH, Banerjee J, Wamai RG, Tobian AAR, Gray RH, et al. A ’snip’ in time: what is the best age to circum-cise? BMC Pediatrics. 2012; 12: 20.

[21] Folaranmi SE, Corbett HJ, Losty PD. Does application of top-ical steroids for lichen sclerosus (balanitis xerotica obliterans) affect the rate of circumcision? A systematic review. Journal of Pediatric Surgery. 2018; 53: 2225–2227.

[22] Kirtschig G, Becker K, Günthert A, Jasaitiene D, Cooper S, Chi C-, et al. Evidence-based (S3) guideline on (anogenital) lichen sclerosus. Journal of the European Academy of Dermatology and Venereology. 2015; 29: e1–e43.

[23] Iskit S, Ilkit M, Turç-Biçer A, Demirhindi H, Türker M. Effect of circumcision on genital colonization of Malassezia spp. in a pediatric population. Medical Mycology. 2006; 44: 113–117.

[24] Mukherjee S, Joshi A, Carroll D, Chandran H, Parashar K, Mc-Carthy L. What is the effect of circumcision on risk of urinary tract infection in boys with posterior urethral valves? Journal of Pediatric Surgery. 2009; 44: 417–421.

[25] Shaikh N, Morone NE, Lopez J, Chianese J, Sangvai S, D’Amico F, et al. Does this child have a urinary tract infection?Journal of the American Medical Association. 2007; 298: 2895–2904.

[26] Bader M, McCarthy L. What is the efficacy of circumcision in boys with complex urinary tract abnormalities? Pediatric Nephrology. 2013; 28: 2267–2272.

[27] Shaikh N, Morone NE, Bost JE, Farrell MH. Prevalence of uri-nary tract infection in childhood: A meta-analysis. The Pediatric Infectious Disease Journal. 2008; 27: 302–308.

[28] Chon CH, Lai FC, Shortliffe LM. Pediatric urinary tract infec-tions. Pediatric Clinics of North America. 2001; 48: 1441–1459.

[29] Schoen EJ. Circumcision for preventing urinary tract infections in boys: North American view. Archives of Disease in Child-hood. 2005; 90: 772–773.

[30] Sureshkumar P, Jones M, Cumming RG, Craig JC. Risk factors for urinary tract infection in children: A population-based study of 2856 children. Journal of Paediatrics and Child Health. 2009; 45: 87–97.

[31] Rushton HG, Majd M. Pyelonephritis in male infants: how im-portant is the foreskin? The Journal of Urology. 1992; 148: 733–738.

[32] Stull TL, LiPuma JJ. Epidemiology and natural history of uri-nary tract infections in children. Medical Clinics of North Amer-ica. 1991; 75: 287–297.

[33] Wiswell TE. The prepuce, urinary tract infections, and the con-sequences. Pediatrics. 2000; 105: 860–862.

[34] Svoboda JS. Circumcision of male infants as a human rights vi-olation. Journal of Medical Ethics. 2013; 39: 469–474.

[35] Svoboda JS, Adler PW, Van Howe RS. Circumcision is unethical and unlawful. The Journal of Law, Medicine & Ethics. 2016; 44: 263–282.

[36] Morris BJ, Tobian AAR. Legal threat to infant male circumci-sion. JAMA Pediatrics. 2013; 167: 890.

[37] Long SS. Can lumbar puncture be deferred in febrile neonates with suspected UTI? The Journal of Pediatrics. 2017; 184: 3.

[38] Looke DFM, Gottlieb T, Jones CA, Paterson DL. Gram‐negative resistance: can we combat the coming of a new “Red Plague”?Medical Journal of Australia. 2013; 198: 243–244.

[39] Wang J, He L, Sha J, Zhu H, Huang L, Zhu X, et al. Etiology and antimicrobial resistance patterns in pediatric urinary tract infection. Pediatrics International. 2018; 60: 418–422.

[40] Arshad M, Seed PC. Urinary tract infections in the infant. Clinics in Perinatology. 2015; 42: 17–28, vii.

[41] Rushton HG. Urinary tract infections in children. Epidemiology, evaluation, and management. Pediatric Clinics of North Amer-ica. 1997; 44: 1133–1169.

[42] Zorc JJ, Kiddoo DA, Shaw KN. Diagnosis and management of pediatric urinary tract infections. Clinical Microbiology Re-views. 2005; 18: 417–422.

[43] Roberts JA. Neonatal circumcision: an end to the controversy?Southern Medical Journal. 1996; 89: 167–171.

[44] Benador D, Benador N, Slosman D, Mermillod B, Girardin E. Are younger children at highest risk of renal sequelae after pyelonephritis? Lancet. 1997; 349: 17–19.

[45] Rushton HG. The evaluation of acute pyelonephritis and re-nal scarring with technetium 99m-dimercaptosuccinic acid renal scintigraphy: evolving concepts and future directions. Pediatric Nephrology. 1997; 11: 108–120.

[46] Shim YH, Lee JW, Lee SJ. The risk factors of recurrent urinary tract infection in infants with normal urinary systems. Pediatric Nephrology. 2009; 24: 309–312.

[47] Alsaywid BS, Saleh H, Deshpande A, Howman-Giles R, Smith GHH. High grade primary vesicoureteral reflux in boys: long-term results of a prospective cohort study. The Journal of Urol-ogy. 2010; 184: 1598–1603.

[48] Wiswell TE, Miller GM, Gelston HM, Jr, Jones SK. Effects of circumcision status on periurethral bacterial flora during the first year of life. Journal of Paediatics. 1988; 113: 442–446.

[49] Fussell EN, Kaack MB, Cherry R, Roberts JA. Adherence of bacteria to human foreskins. The Journal of Urology. 1988; 140: 997–1001.

[50] Wijesinha SS, Atkins BL, Dudley NE, Tam PK. Does circum-cision alter the periurethral bacterial flora? Pediatric Surgery International. 1998; 13: 146–148.

[51] Gücük A, Burgu B, Gökçe İ, Mermerkaya M, Soygür T. Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR? Journal of Pediatric Urology. 2013; 9: 1131–1136.

[52] Ladenhauf HN, Ardelean MA, Schimke C, Yankovic F, Schimpl G. Reduced bacterial colonisation of the glans penis after male circumcision in children—a prospective study. Journal of Pedi-atric Urology. 2013; 9: 1137–1144.

[53] Kose E, Yavascan O, Turan O, Kangin M, Bal A, Alparslan C, et al. The effect of circumcision on the frequency of urinary tract infection, growth and nutrition status in infants with antenatal hydronephrosis. Renal Failure. 2013; 35: 1365–1369.

[54] Ellison JS, Dy GW, Fu BC, Holt SK, Gore JL, Merguerian PA. Neonatal circumcision and urinary tract infections in infants with hydronephrosis. Pediatrics. 2018; 142: e20173703.

[55] Morris BJ, Wiswell TE. Circumcision and lifetime risk of uri-nary tract infection: A systematic review and meta-analysis. The Journal of Urology. 2013; 189: 2118–2124.

[56] Wiswell TE, Hachey WE. Urinary tract infections and the cir-cumcision state: An update. Clinical Pediatrics. 1993; 32: 130–134.

[57] Singh-Grewal D, Macdessi J, Craig J. Circumcision for the pre-vention of urinary tract infection in boys: A systematic review of randomised trials and observational studies. Archives of Disease in Childhood. 2005; 90: 853–858.

[58] Craig JC, Knight JF, Sureshkumar P, Mantz E, Roy LP. Effect of circumcision on incidence of urinary tract infection in preschool boys. The Journal of Pediatrics. 1996; 128: 23–27.

[59] Jakobsson B, Esbjörner E, Hansson S. Minimum incidence and diagnostic rate of first urinary tract infection. Pediatrics. 1999; 104: 222–226.

[60] Coulthard MG, Lambert HJ, Keir MJ. Occurrence of renal scars in children after their first referral for urinary tract infection. British Medical Journal. 1997; 315: 918–919.

[61] Schoen EJ, Colby CJ, Ray GT. Newborn circumcision decreases incidence and costs of urinary tract infections during the first year of life. Pediatrics. 2000; 105: 789–793.

[62] Fiore AE, Shay DK, Haber P, Iskander JK, Uyeki TM, Mootrey G, et al. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. Morbidity and Mortality Weekly Report. Recommenda-tions and Reports. 2007; 56: 1–54.

[63] Kelly H, Carville K, Grant K, Jacoby P, Tran T, Barr I. Estima-tion of influenza vaccine effectiveness from routine surveillance data. PLoS One. 2009; 4: e5079.

[64] Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male cir-cumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Medicine. 2005; 2: e298.

[65] Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: A randomised controlled trial. The Lancet. 2007; 369: 643–656.

[66] Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalu-goda F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: A randomised trial. Lancet. 2007; 369: 657–666.

[67] Weiss HA, Halperin D, Bailey RC, Hayes RJ, Schmid G, Hank-ins CA. Male circumcision for HIV prevention: from evidence to action? AIDS. 2008; 22: 567–574.

[68] Siegfried N, Muller M, Deeks JJ, Volmink J. Male circumcision for prevention of heterosexual acquisition of HIV in men. The Cochrane Database of Systematic Reviews. 2009: CD003362.

[69] Lei JH, Liu LR, Wei Q, Yan SB, Yang L, Song TR, et al. Cir-cumcision status and risk of HIV acquisition during heterosexual intercourse for both males and females: A meta-analysis. PLoS ONE. 2015; 10: e0125436.

[70] Sharma SC, Raison N, Khan S, Shabbir M, Dasgupta P, Ahmed K. Male circumcision for the prevention of human immunode-ficiency virus (HIV) acquisition: A meta-analysis. BJU Interna-tional. 2018; 121: 515–526.

[71] Kabwama SN, Ssewanyana D, Berg-Beckhoff G. The associa-tion between male circumcision and condom use behavior - A meta-analysis. Materia Socio-Medica. 2018; 30: 62–66.

[72] Centers for Disease Control and Prevention. Male circumcision. 2018. Available at: ision.html (Accessed: 25 October 2021).

[73] Smith DK, Taylor A, Kilmarx PH, Sullivan P, Warner L, Kamb M, et al. Male circumcision in the United States for the preven-tion of HIV infection and other adverse health outcomes: report from a CDC consultation. Public Health Reports. 2010; 125: 72–82.

[74] Warner L, Ghanem KG, Newman DR, Macaluso M, Sullivan PS, Erbelding EJ. Male circumcision and risk of HIV infection among heterosexual African American men attending Baltimore sexually transmitted disease clinics. The Journal of Infectious Diseases. 2009; 199: 59–65.

[75] Sansom SL, Prabhu VS, Hutchinson AB, An Q, Hall HI, Shrestha RK, et al. Cost-effectiveness of newborn circumcision in reducing lifetime HIV risk among U.S. males. PLoS One. 2010; 5: article e8723.

[76] Chemtob D, Op de Coul E, van Sighem A, Mor Z, Cazein F, Se-maille C. Impact of male circumcision among heterosexual HIV cases: comparisons between three low HIV prevalence coun-tries. Israel Journal of Health Policy Research. 2015; 4: 36.

[77] Morris BJ, Bailey RC, Klausner JD, Leibowitz A, Wamai RG, Waskett JH, et al. Review: A critical evaluation of arguments opposing male circumcision for HIV prevention in developed countries. AIDS Care. 2012; 24: 1565–1575.

[78] Morris BJ, Moreton S, Krieger JN. Critical evaluation of argu-ments opposing male circumcision: A systematic review. Jour-nal of Evidence-Based Medicine. 2019; 12: 263–290.

[79] Cooper DA, Wodak AD, Morris BJ. The case for boosting infant male circumcision in the face of rising heterosexual transmission of HIV. The Medical Journal of Australia. 2010; 193: 318–319.

[80] Szabo R, Short RV. How does male circumcision protect against HIV infection? British Medical Journal. 2000; 320: 1592–1594.

[81] McCoombe SG, Short RV. Potential HIV-1 target cells in the human penis. AIDS. 2006; 20: 1491–1495.

[82] Hirbod T, Bailey RC, Agot K, Moses S, Ndinya-Achola J, Mu-rugu R, et al. Abundant expression of HIV target cells and C-type lectin receptors in the foreskin tissue of young Kenyan men. The American Journal of Pathology. 2010; 176: 2798–2805.

[83] Ganor Y, Zhou Z, Tudor D, Schmitt A, Vacher-Lavenu M, Gibault L, et al. Within 1 h, HIV-1 uses viral synapses to enter efficiently the inner, but not outer, foreskin mucosa and engages Langerhans-T cell conjugates. Mucosal Immunology. 2010; 3: 506–522.

[84] Ganor Y, Bomsel M. HIV-1 transmission in the male genital tract. American Journal of Reproductive Immunology. 2011; 65: 284–291.

[85] Morris BJ, Wamai RG. Biological basis for the protective effect conferred by male circumcision against HIV infection. Interna-tional Journal of STD & AIDS. 2012; 23: 153–159.

[86] Gray RH, Serwadda D, Tobian AAR, Chen MZ, Makumbi F, Suntoke T, et al. Effects of genital ulcer disease and herpes simplex virus type 2 on the efficacy of male circumcision for HIV prevention: analyses from the Rakai trials. PLoS Medicine. 2009; 6: e1000187.

[87] Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increases HIV acqui-sition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS. 2006; 20: 73–83.

[88] Boily M, Desai K, Masse B, Gumel A. Incremental role of male circumcision on a generalised HIV epidemic through its protec-tive effect against other sexually transmitted infections: from efficacy to effectiveness to population-level impact. Sexually Transmitted Infections. 2008; 84: ii28–ii34.

[89] Tobian AA, Quinn TC. Herpes simplex virus type 2 and syphilis infections with HIV: An evolving synergy in transmission and prevention. Current Opinion in HIV and AIDS. 2009; 4: 294–299.

[90] Bailey R, Mehta S. Circumcision’s place in the vicious cycle involving herpes simplex virus type 2 and HIV. The Journal of Infectious Diseases. 2009; 199: 923–925.

[91] Brito MO, Khosla S, Pananookooln S, Fleming PJ, Lerebours L, Donastorg Y, et al. Sexual pleasure and function, coital trauma, and sex behaviors after voluntary medical male circumcision among men in the Dominican Republic. The Journal of Sexual Medicine. 2017; 14: 526–534.

[92] Mehta SD, Krieger JN, Agot K, Moses S, Ndinya-Achola JO, Parker C, et al. Circumcision and reduced risk of self-reported penile coital injuries: results from a randomized controlled trial in Kisumu, Kenya. The Journal of Urology. 2010; 184: 203–209.

[93] Westercamp N, Mehta SD, Jaoko W, Okeyo TA, Bailey RC. Pe-nile coital injuries in men decline after circumcision: Results from a prospective study of recently circumcised and uncircum-cised men in western Kenya. PLoS One. 2017; 12: e0185917.

[94] Kigozi G, Wawer M, Ssettuba A, Kagaayi J, Nalugoda F, Watya S, et al. Foreskin surface area and HIV acquisition in Rakai, Uganda (size matters). AIDS. 2009; 23: 2209–2213.

[95] de Witte L, Nabatov A, Pion M, Fluitsma D, de Jong MAWP, de Gruijl T, et al. Langerin is a natural barrier to HIV-1 transmission by langerhans cells. Nature Medicine. 2007; 13: 367–371.

[96] Schwartz O. Langerhans cells lap up HIV-1. Nature Medicine. 2007; 13: 245–246.

[97] Tobian AAR, Kong X, Gravitt PE, Eaton KP, Kigozi G, Ser-wadda D, et al. Male circumcision and anatomic sites of penile high-risk human papillomavirus in Rakai, Uganda. International Journal of Cancer. 2011; 129: 2970–2975.

[98] Albero G, Castellsagué X, Giuliano AR, Bosch FX. Male cir-cumcision and genital human papillomavirus: A systematic re-view and meta-analysis. Sexually Transmitted Diseases. 2012; 39: 104–113.

[99] Larke N, Thomas SL, Dos Santos Silva I, Weiss HA. Male cir-cumcision and human papillomavirus infection in men: A sys-tematic review and meta-analysis. The Journal of Infectious Dis-eases. 2011; 204: 1375–1390.

[100] Zhu Y, Jia Z, Dai B, Ye D, Kong Y, Chang K, et al. Relation-ship between circumcision and human papillomavirus infection: A systematic review and meta-analysis. Asian Journal of An-drology. 2017; 19: 125–131.

[101] Backes DM, Bleeker MCG, Meijer CJLM, Hudgens MG, Agot K, Bailey RC, et al. Male circumcision is associated with a lower prevalence of human papillomavirus-associated penile lesions among Kenyan men. International Journal of Cancer. 2012; 130: 1888–1897.

[102] Gray RH, Serwadda D, Kong X, Makumbi F, Kigozi G, Gravitt PE, et al. Male circumcision decreases acquisition and increases clearance of high-risk human papillomavirus in HIV-negative men: A randomized trial in Rakai, Uganda. The Journal of In-fectious Diseases. 2010; 201: 1455–1462.

[103] Senkomago V, Backes DM, Hudgens MG, Poole C, Agot K, Moses S, et al. Acquisition and persistence of human papillo-mavirus 16 (HPV-16) and HPV-18 among men with high-HPV viral load infections in a circumcision trial in Kisumu, Kenya. The Journal of Infectious Diseases. 2015; 211: 811–820.

[104] Tobian AAR, Serwadda D, Quinn TC, Kigozi G, Gravitt PE, Laeyendecker O, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. New England Journal of Medicine. 2009; 360: 1298–1309.

[105] Wilson LE, Gravitt P, Tobian AAR, Kigozi G, Serwadda D, Nalugoda F, et al. Male circumcision reduces penile high-risk human papillomavirus viral load in a randomised clinical trial in Rakai, Uganda. Sexually Transmitted Infections. 2013; 89: 262–266.

[106] Auvert B, Sobngwi-Tambekou J, Cutler E, Nieuwoudt M, Lis-souba P, Puren A, et al. Effect of male circumcision on the prevalence of high-risk human papillomavirus in young men: re-sults of a randomized controlled trial conducted in Orange Farm, South Africa. The Journal of Infectious Diseases. 2009; 199: 14–19.

[107] Castellsagué X, Bosch FX, Muñoz N, Meijer CJLM, Shah KV, de Sanjosé S, et al. Male circumcision, penile human papillo-mavirus infection, and cervical cancer in female partners. New England Journal of Medicine. 2002; 346: 1105–1112.

[108] Homfray V, Tanton C, Miller RF, Beddows S, Field N, Sonnen-berg P, et al. Male circumcision and STI acquisition in Britain: evidence from a national probability sample survey. PLoS One. 2015; 10: e0130396.

[109] Hernandez BY, Shvetsov YB, Goodman MT, Wilkens LR, Thompson P, Zhu X, et al. Reduced clearance of penile human papillomavirus infection in uncircumcised men. The Journal of Infectious Diseases. 2010; 201: 1340–1343.

[110] Lu B, Wu Y, Nielson CM, Flores R, Abrahamsen M, Papenfuss M, et al. Factors associated with acquisition and clearance of hu-man papillomavirus infection in a cohort of us men: A prospec-tive study. The Journal of Infectious Diseases. 2009; 199: 362–371.

[111] Afonso LA, Cordeiro TI, Carestiato FN, Ornellas AA, Alves G, Cavalcanti SMB. High risk human papillomavirus infection of the foreskin in asymptomatic men and patients with phimosis. The Journal of Urology. 2016; 195: 1784–1789.

[112] Tobian AAR, Ssempijja V, Kigozi G, Oliver AE, Serwadda D, Makumbi F, et al. Incident HIV and herpes simplex virus type 2 infection among men in Rakai, Uganda. AIDS. 2009; 23: 1589–1594.

[113] Tobian AA, Charvat B, Ssempijja V, Kigozi G, Serwadda D, Makumbi F, et al. Factors associated with the prevalence and incidence of herpes simplex virus type 2 infection among men in Rakai, Uganda. The Journal of Infectious Diseases. 2009; 199: 945–949.

[114] Sobngwi‐Tambekou J, Taljaard D, Lissouba P, Zarca K, Puren A, Lagarde E, et al. Effect of HSV‐2 serostatus on acquisition of HIV by young men: results of a longitudinal study in orange farm, South Africa. The Journal of Infectious Diseases. 2009; 199: 958–964.

[115] Mehta SD, Moses S, Agot K, Maclean I, Odoyo-June E, Li H, et al. Medical male circumcision and HSV-2 acquisition: Post-trial surveillance in Kisumu, Kenya. Journal of Infectious Diseases. 2013; 208: 1869–1876.

[116] Sobngwi-Tambekou J, Taljaard D, Nieuwoudt M, Lissouba P, Puren A, Auvert B. Male circumcision and Neisseria gonor-rhoeae, Chlamydia trachomatis, and Trichomonas vaginalis: observations in the aftermath of a randomised controlled trial for HIV prevention. Sexually Transmitted Infections. 2009; 85: 116–120.

[117] Mehta SD, Gaydos C, Maclean I, Odoyo-June E, Moses S, Agunda L, et al. The effect of medical male circumcision on uro-genital Mycoplasma genitalium among men in Kisumu, Kenya. Sexually Transmitted Diseases. 2012; 39: 276–280.

[118] Weiss HA, Thomas SL, Munabi SK, Hayes RJ. Male circum-cision and risk of syphilis, chancroid, and genital herpes: a sys-tematic review and Meta-analysis. Sexually Transmitted Infec-tions. 2006; 82: 101–9; discussion 110.

[119] Pintye J, Baeten JM, Manhart LE, Celum C, Ronald A, Mugo N, et al. Association between male circumcision and incidence of syphilis in men and women: a prospective study in HIV-1 serodiscordant heterosexual African couples. The Lancet. Global Health. 2014; 2: e664–e671.

[120] Otieno-Nyunya B, Bennett E, Bunnell R, Dadabhai S, Gichangi A A, Mugo N, et al. Epidemiology of syphilis in Kenya: re-sults from a nationally representative serological survey. Sexu-ally Transmitted Infections. 2011; 87: 521–525.

[121] Nasio JM, Nagelkerke NJ, Mwatha A, Moses S, Ndinya-Achola JO, Plummer FA. Genital ulcer disease among STD clinic attenders in Nairobi: association with HIV-1 and circum-cision status. International Journal of STD & AIDS. 1996; 7: 410–414.

[122] Mehta SD, Moses S, Parker CB, Agot K, Maclean I, Bailey RC. Circumcision status and incident herpes simplex virus type 2 in-fection, genital ulcer disease, and HIV infection. AIDS. 2012; 26: 1141–1149.

[123] Liu CM, Hungate BA, Tobian AAR, Serwadda D, Ravel J, Lester R, et al. Male circumcision significantly reduces preva-lence and load of genital anaerobic bacteria. MBio. 2013; 4: e00076.

[124] Mehta S, Moses S, Agot K, Parker C, Ndinya‐Achola J, Maclean I, et al. Adult male circumcision does not reduce the risk of incident neisseria gonorrhoeae, Chlamydia trachomatis, or Trichomonas vaginalis infection: results from a randomized, controlled trial in Kenya. The Journal of Infectious Diseases. 2009; 200: 370–378.

[125] Waskett JH, Morris BJ, Weiss HA. Errors in meta-analysis by Van Howe. International Journal of STD & AIDS. 2009; 20: 216–220.

[126] Tobian AAR, Gray RH. The Medical benefits of male circum-cision. Journal of the American Medical Association. 2011; 306: 1479.

[127] Tobian AAR, Kacker S, Quinn TC. Male circumcision: a glob-ally relevant but under-utilized method for the prevention of HIV and other sexually transmitted infections. Annual Review of Medicine. 2014; 65: 293–306.

[128] Morris BJ, Hankins CA, Tobian AAR, Krieger JN, Klausner JD. Does male circumcision protect against sexually transmitted infections? Arguments and meta-analyses to the contrary fail to withstand scrutiny. ISRN Urology. 2014; 2014: 1–23.

[129] Morris BJ, Wamai RG, Krieger JN, Banerjee J, Klausner JD. Male circumcision to prevent syphilis in 1855 and HIV in 1986 is supported by the accumulated scientific evidence to 2015: Re-sponse to Darby. Global Public Health. 2017; 12: 1315–1333.

[130] Grund JM, Bryant TS, Jackson I, Curran K, Bock N, Toledo C, et al. Association between male circumcision and women’s biomedical health outcomes: A systematic review. The Lancet. Global Health. 2017; 5: e1113–e1122.

[131] Morris BJ, Hankins CA, Banerjee J, Lumbers ER, Mindel A, Klausner JD, et al. Does male circumcision reduce women’s risk of sexually transmitted infections, cervical cancer, and associ-ated conditions? Frontiers in Public Health. 2019; 7: 4.

[132] Morris BJ, Hankins CA. Effect of male circumcision on risk of sexually transmitted infections and cervical cancer in women. The Lancet. Global Health. 2017; 5: e1054–e1055.

[133] Fatti G, Shaikh N, Jackson D, Goga A, Nachega JB, Eley B, et al. Low HIV incidence in pregnant and postpartum women re-ceiving a community-based combination HIV prevention inter-vention in a high HIV incidence setting in South Africa. PLoS One. 2017; 12: e0181691.

[134] Weiss HA, Hankins CA, Dickson K. Male circumcision and risk of HIV infection in women: a systematic review and meta-analysis. the Lancet. Infectious Diseases. 2009; 9: 669–677.

[135] Wawer MJ, Makumbi F, Kigozi G, Serwadda D, Watya S, Nalugoda F, et al. Circumcision in HIV-infected men and its ef-fect on HIV transmission to female partners in Rakai, Uganda: A randomised controlled trial. The Lancet. 2009; 374: 229–237.

[136] Martín-Sánchez M, Case R, Fairley C, Hocking JS, Bradshaw C, Ong J, et al. Trends and differences in sexual practices and sexually transmitted infections in men who have sex with men only (MSMO) and men who have sex with men and women (MSMW): A repeated cross-sectional study in Melbourne, Aus-tralia. BMJ Open. 2020; 10: e037608.

[137] Wiysonge CS, Kongnyuy EJ, Shey M, Muula AS, Navti OB, Akl EA, et al. Male circumcision for prevention of homosexual acquisition of HIV in men. The Cochrane Database of System-atic Reviews. 2011: CD007496.

[138] Yuan T, Fitzpatrick T, Ko N, Cai Y, Chen Y, Zhao J, et al. Cir-cumcision to prevent HIV and other sexually transmitted infec-tions in men who have sex with men: A systematic review and meta-analysis of global data. The Lancet Global Health. 2019; 7: e436–e447.

[139] Pintye J, Baeten JM. Benefits of male circumcision for MSM: evidence for action. The Lancet Global Health. 2019; 7: e388–e389.

[140] Templeton DJ, Jin F, Mao L, Prestage GP, Donovan B, Imrie J, et al. Circumcision and risk of HIV infection in Australian homosexual men. AIDS. 2009; 23: 2347–2351.

[141] Poynten IM, Jin F, Templeton DJ, Prestage GP, Donovan B, Pawlita M, et al. Prevalence, incidence, and risk factors for hu-man papillomavirus 16 seropositivity in Australian homosexual men. Sexually Transmitted Diseases. 2012; 39: 726–732.

[142] Templeton DJ, Jin F, Prestage GP, Donovan B, Imrie JC, Kip-pax SC, et al. Circumcision and risk of sexually transmissible infections in a community-based cohort of HIV-negative homo-sexual men in Sydney, Australia. The Journal of Infectious Dis-eases. 2009; 200: 1813–1819.

[143] Weller S, Davis K. Condom effectiveness in reducing hetero-sexual HIV transmission. The Cochrane Database of Systematic Reviews. 2002: CD003255.

[144] Giannou FK, Tsiara CG, Nikolopoulos GK, Talias M, Bene-tou V, Kantzanou M, et al. Condom effectiveness in reducing heterosexual HIV transmission: A systematic review and meta-analysis of studies on HIV serodiscordant couples. Expert Re-view of Pharmacoeconomics & Outcomes Research. 2016; 16: 489–499.

[145] Hearst N, Chen S. Condom promotion for AIDS prevention in the developing world: is it working? Studies in Family Planning. 2004; 35: 39–47.

[146] Lopez LM, Otterness C, Chen M, Steiner M, Gallo MF. Be-havioral interventions for improving condom use for dual pro-tection. The Cochrane Database of Systematic Reviews. 2013: CD010662.

[147] Kochen M. Circumcision and the risk of cancer of the penis. American Journal of Diseases of Children. 1980; 134: 484.

[148] Wiswell TE. Neonatal circumcision: A current appraisal. Fo-cus & Opinion. Pediatrics. 1995; 1: 93–99.

[149] Wiswell TE. Circumcision circumspection. The New England Journal of Medicine. 1997; 336: 1244–1245.

[150] Sewell J, Ranasinghe W, De Silva D, Ayres B, Ranasinghe T, Hounsome L, et al. Trends in penile cancer: A compara-tive study between Australia, England and Wales, and the us. SpringerPlus. 2015; 4: 420.

[151] Schoen EJ, Oehrli M, Colby CD, Machin G. The highly pro-tective effect of newborn circumcision against invasive penile cancer. Pediatrics. 2000; 105: E36.

[152] Ahmed ME, Khalil MI, Kamel MH, Karnes RJ, Spiess PE. Progress on management of penile cancer in 2020. Current Treatment Options in Oncology. 2020; 22: 4.

[153] Harju E, Pakarainen T, Vasarainen H, Törnävä M, Helminen M, Perttilä I, et al. Health-related quality of life, self-esteem and sexual functioning among patients operated for penile cancer –A cross-sectional study. The Journal of Sexual Medicine. 2021; 18: 1524–1531.

[154] Morris BJ, Gray RH, Castellsague X, Bosch FX, Halperin DT, Waskett JH, et al. The strong protective effect of circumcision against cancer of the penis. Advances in Urology. 2011; 2011: 812368.

[155] Morris BJ, Mindel A, Tobian AA, Hankins CA, Gray RH, Bai-ley RC, et al. Should male circumcision be advocated for genital cancer prevention? Asian Pacific Journal of Cancer Prevention. 2012; 13: 4839–4842.

[156] Harder T, Wichmann O, Klug SJ, van der Sande MAB, Wiese-Posselt M. Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: A systematic review. BMC Medicine. 2018; 16: 110.

[157] Australian Government. Australian Institute of Health and Wel-fare. Prostate cancer in Australia statistics. 2022. Available at:

- types/prostate-cancer/prostate-cancer-australia-statistics (Ac-cessed: 26 October 2021).

[158] Morris BJ, Waskett JH. Circumcision reduces prostate cancer risk. Asian Journal of Andrology. 2012; 14: 661–662.

[159] Wachtel MS, Yang S, Morris BJ. Countries with high circumci-sion prevalence have lower protate cancer mortality. Asian Jour-nal of Andrology. 2016; 18: 39–42.

[160] Pabalan N, Singian E, Jarjanazi H, Paganini-Hill A. Associa-tion of male circumcision with risk of prostate cancer: a meta-analysis. Prostate Cancer and Prostatic Diseases. 2015; 18: 352–357.

[161] Li YD, Teng Y, Dai Y, Ding H. The association of circumcision and prostate cancer: A meta-analysis. Asian Pacific Journal of Cancer Prevention. 2016; 17: 3823–3827.

[162] Morris BJ, Matthews JG, Pabalan N, Moreton S, Krieger JN. Male circumcision and prostate cancer: A meta-analysis re-visited. Canadian Journal of Urology. 2021; 28: 10768–10776.

[163] Wright JL, Lin DW, Stanford JL. Circumcision and the risk of prostate cancer. Cancer. 2012; 118: 4437–4443.

[164] Spence AR, Rousseau MC, Karakiewicz PI, Parent ME. Cir-cumcision and prostate cancer: A population-based case-control study in Montreal, Canada. BJU International. 2014; 114: E90–E98.

[165] Morris BJ, Waskett J, Bailis SA. Case number and the financial impact of circumcision in reducing prostate cancer. BJU Inter-national. 2007; 100: 5–6.

[166] American Cancer Society. Prostate cancer risk factors. 2022. Available at: uses-risks-prevention/risk-factors.html (Accessed: 26 October 2021).

[167] Drain PK, Halperin DT, Hughes JP, Klausner JD, Bailey RC. Male circumcision, religion, and infectious diseases: an eco-logic analysis of 118 developing countries. BMC Infectious Dis-eases. 2006; 6: 172.

[168] Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de San-josé S. Cervical human papillomavirus prevalence in 5 conti-nents: meta-analysis of 1 million women with normal cytolog-ical findings. The Journal of Infectious Diseases. 2010; 202: 1789–1799.

[169] Shavit O, Roura E, Barchana M, Diaz M, Bornstein J. Burden of human papillomavirus infection and related diseases in Israel. Vaccine. 2013; 31: I32–I41.

[170] Al-Awadhi R, Chehadeh W, Kapila K. Prevalence of human papillomavirus among women with normal cervical cytology in Kuwait. Journal of Medical Virology. 2011; 83: 453–460.

[171] Svare EI, Kjaer SK, Worm AM, Osterlind A, Meijer CJLM, van den Brule AJC. Risk factors for genital HPV DNA in men resemble those found in women: A study of male attendees at a Danish STD clinic. Sexually Transmitted Infections. 2002; 78: 215–218.

[172] Aung MT, Soe MY, Mya WW. Study on risk factors for cer-vical carcinoma at Central Womens Hospital, Yangon, Myan-mar. 10th International Scientific Congress of the Royal Col-lege of Obstetricians and Gynaecologists, RCOG 2012 Kuching, Sarawak Malaysia. British Journal of Obstetrics and Gynaecol-ogy. 2012; 119: 124.

[173] Kim J, Kim BK, Lee CH, Seo SS, Park S, Roh J. Human pa-pillomavirus genotypes and cofactors causing cervical intraep-ithelial neoplasia and cervical cancer in Korean women. Interna-tional Journal of Gynecological Cancer. 2012; 22: 1570–1576.

[174] Roura E, Iftner T, Vidart JA, Kjaer SK, Bosch FX, Muñoz N, et al. Predictors of human papillomavirus infection in women un-dergoing routine cervical cancer screening in Spain: the cleopa-tre study. BMC Infectious Diseases. 2012; 12: 145.

[175] Obiri-Yeboah D, Akakpo PK, Mutocheluh M, Adjei-Danso E, Allornuvor G, Amoako-Sakyi D, et al. Epidemiology of cervical human papillomavirus (HPV) infection and squamous intraep-ithelial lesions (SIL) among a cohort of HIV-infected and unin-fected Ghanaian women. BMC Cancer. 2017; 17: 688.

[176] Kolawole O, Olatunji K, Durowade K, Adeniyi A, Omokanye

L. Prevalence, risk factors of human papillomavirus infection and papanicolaou smear pattern among women attending a tertiary health facility in south-west Nigeria. TAF Preventive Medicine Bulletin. 2015; 14: 453.

[177] Bosch FX, Albero G, Castellsagué X. Male circumcision, hu-man papillomavirus and cervical cancer: from evidence to in-tervention. The Journal of Family Planning and Reproductive Health Care. 2009; 35: 5–7.

[178] Bruni L, Diaz M, Barrionuevo-Rosas L, Herrero R, Bray F, Bosch FX, et al. Global estimates of human papillomavirus vac-cination coverage by region and income level: A pooled analy-sis. The Lancet. Global Health. 2016; 4: e453–e463.

[179] Hall MT, Simms KT, Lew J, Smith MA, Brotherton JM, Saville M, et al. The projected timeframe until cervical cancer elimina-tion in Australia: A modelling study. The Lancet Public Health. 2019; 4: e19–e27.

[180] Garland SM, Kjaer SK, Muñoz N, Block SL, Brown DR, DiN-ubile MJ, et al. Impact and effectiveness of the quadrivalent Hu-man papillomavirus vaccine: A systematic review of 10 years of real-world experience. Clinical Infectious Diseases. 2016; 63: 519–527.

[181] Freire-Salinas J, Benito R, Azueta A, Gil J, Mendoza C, Nicolás M, et al. Genotype distribution change after human pa-pillomavirus vaccination in two autonomous communities in Spain. Frontiers in Cellular and Infection Microbiology. 2021; 11: 633162.

[182] Morris BJ, Flanagan JL, McKinnon KJ, Nightingale BN. Pa-pillomavirus screening of cervical lavages by polymerase chain reaction. Lancet. 1988; 2: 1368.

[183] Morris BJ. The advent of human papillomavirus detection for cervical screening. Current Opinion in Obstetrics & Gynecol-ogy. 2019; 31: 333–339.

[184] Morris BJ, Wodak AD. Causes and consequences of the decline in circumcision in Australia. ANZ Journal of Surgery. 2021; 91: 2546–2547.

[185] Many BT, Rizeq YK, Vacek J, Cheon EC, Johnson E, Hu Y, et al. A contemporary snapshot of circumcision in us children’s hospitals. Journal of Pediatric Surgery. 2020; 55: 1134–1138.

[186] Morris BJ, Bailis SA, Wiswell TE. Circumcision rates in the United States: rising or falling? What effect might the new affir-mative pediatric policy statement have? Mayo Clinic Proceed-ings. 2014; 89: 677–686.

[187] Kigozi G, Watya S, Polis CB, Buwembo D, Kiggundu V, Wawer MJ, et al. The effect of male circumcision on sexual satisfaction and function, results from a randomized trial of male circumcision for human immunodeficiency virus preven-tion, Rakai, Uganda. BJU International. 2008; 101: 65–70.

[188] Krieger JN, Mehta SD, Bailey RC, Agot K, Ndinya-Achola JO, Parker C, et al. Adult male circumcision: effects on sexual func-tion and sexual satisfaction in Kisumu, Kenya. The Journal of Sexual Medicine. 2008; 5: 2610–2622.

[189] Homfray V, Tanton C, Mitchell KR, Miller RF, Field N, Mac-dowall W, et al. Examining the association between male cir-cumcision and sexual function: evidence from a British proba-bility survey. AIDS. 2015; 29: 1411–1416.

[190] Morris BJ, Krieger JN. Does male circumcision affect sexual function, sensitivity, or satisfaction?—A systematic review. The Journal of Sexual Medicine. 2013; 10: 2644–2657.

[191] Tian Y, Liu W, Wang J, Wazir R, Yue X, Wang K. Effects of circumcision on male sexual functions: A systematic review and meta-analysis. Asian Journal of Andrology. 2013; 15: 662–666.

[192] Yang Y, Wang X, Bai Y, Han P. Circumcision does not have effect on premature ejaculation: A systematic review and meta-analysis. Andrologia. 2018; 50.

[193] Shabanzadeh DM, Düring S, Frimont-Moller C. Male circum-cision does not result in inferior perceived male sexual function –A systematic review. Danish Medical Journal. 2016; 63: A5245.

[194] Mao L, Templeton DJ, Crawford J, Imrie J, Prestage GP, Grulich AE, et al. Does circumcision make a difference to the sexual experience of gay men? Findings from the Health in Men (HIM) cohort. The Journal of Sexual Medicine. 2008; 5: 2557–2561.

[195] Hammond T, Carmack A. Long-term adverse outcomes from neonatal circumcision reported in a survey of 1,008 men: An overview of health and human rights implications. The Interna-tional Journal of Human Rights. 2017; 21: 189–218.

[196] Bailis SA, Moreton S, Morris BJ. Critical evaluation of a sur-vey claiming “long-term adverse outcomes from neonatal cir-cumcision”. Advances in Sexual Medicine. 2019; 09: 67–109.

[197] Bleustein CB, Fogarty JD, Eckholdt H, Arezzo JC, Melman A. Effect of neonatal circumcision on penile neurologic sensation. Urology. 2005; 65: 773–777.

[198] Payne K, Thaler L, Kukkonen T, Carrier S, Binik Y. Sensation and sexual arousal in circumcised and uncircumcised men. The Journal of Sexual Medicine. 2007; 4: 667–674.

[199] Bossio JA, Pukall CF, Steele SS. Examining penile sensitiv-ity in neonatally circumcised and intact men using quantitative sensory testing. The Journal of Urology. 2016; 195: 1848–1853.

[200] Cox G, Krieger JN, Morris BJ. Histological correlates of penile sexual sensation: does circumcision make a difference? Sexual Medicine. 2015; 3: 76–85.

[201] Richters J, Smith AMA, de Visser RO, Grulich AE, Rissel CE. Circumcision in Australia: prevalence and effects on sexual health. International Journal of STD & AIDS. 2006; 17: 547–554.

[202] Morris BJ, Hankins CA, Lumbers ER, Mindel A, Klausner JD, Krieger JN, et al. Sex and male circumcision: women’s prefer-ences across different cultures and countries: A systematic re-view. Sexual Medicine. 2019; 7: 145–161.

[203] Grund JM, Bryant TS, Toledo C, Jackson I, Curran K, Zhou S, et al. Association of male circumcision with women’s knowl-edge of its biomedical effects and with their sexual satisfaction and function: a systematic review. AIDS and Behavior. 2019; 23: 1104–1114.

[204] Aslam M, Kropp RY, Jayaraman G, Dinner K, Wong T, Steben

M. Genital herpes in Canada: deciphering the hidden epidemic. The Canadian Journal of Infectious Diseases & Medical Micro-biology. 2012; 23: e6–e9.

[205] Christakis DA, Harvey E, Zerr DM, Feudtner C, Wright JA, Connell FA. A trade-off analysis of routine newborn circumci-sion. Pediatrics. 2000; 105: 246–249.

[206] Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA: A Cancer Journal for Clinicians. 1995; 45: 8–30.

[207] Wiswell TE, Geschke DW. Risks from circumcision during the first month of life compared with those for uncircumcised boys. Pediatrics. 1989; 83: 1011–1015.

[208] El Bcheraoui C, Zhang X, Cooper CS, Rose CE, Kilmarx PH, Chen RT. Rates of adverse events associated with male circum-cision in US medical settings, 2001 to 2010. JAMA Pediatrics. 2014; 168: 625.

[209] Cathcart P, Nuttall M, van der Meulen J, Emberton M, Kenny SE. Trends in paediatric circumcision and its complications in England between 1997 and 2003. British Journal of Surgery. 2006; 93: 885–890.

[210] Simforoosh N, Tabibi A, Khalili SAR, Soltani MH, Afjehi A, Aalami F, et al. Neonatal circumcision reduces the incidence of asymptomatic urinary tract infection: A large prospective study with long-term follow up using Plastibell. Journal of Pediatric Urology. 2012; 8: 320–323.

[211] Yegane RA, Kheirollahi AR, Salehi NA, Bashashati M, Khoshdel JA, Ahmadi M. Late complications of circumcision in Iran. Pediatric Surgery International. 2006; 22: 442–445.

[212] Zeitler M, Rayala B. Neonatal circumcision. Primary Care: Clinics in Office Practice. 2021; 48: 597–611.

[213] Srinivasan M, Hamvas C, Coplen D. Rates of complications after newborn circumcision in a well-baby nursery, special care nursery, and neonatal intensive care unit. Clinical Pediatriatrics. 2015; 54: 1185–1191.

[214] Weiss HA, Larke N, Halperin D, Schenker I. Complications of circumcision in male neonates, infants and children: A system-atic review. BMC Urology. 2010; 10: 2.

[215] Gyan T, Strobel NA, McAuley K, Shannon C, Newton S, Tawiah‐Agyemang C, et al. Health service provider education and/or training in infant male circumcision to improve short‐ and long‐term morbidity outcomes: A systematic review. Journal of Paediatrics and Child Health. 2019; 55: 895–906.

[216] Fergusson DM, Boden JM, Horwood LJ. Circumcision status and risk of sexually transmitted infection in young adult males: an analysis of a longitudinal birth cohort. Pediatrics. 2006; 118: 1971–1977.

[217] Fergusson DM, Boden JM, Horwood LJ. Neonatal circumci-sion: effects on breastfeeding and outcomes associated with breastfeeding. Journal of Paediatrics and Child Health. 2008; 44: 44–49.

[218] Mondzelewski L, Gahagan S, Johnson C, Madanat H, Rhee K. Timing of circumcision and breastfeeding initiation among new-born boys. Hospital Pediatrics. 2016; 6: 653–658.

[219] Marshall RE, Porter FL, Rogers AG, Moore J, Anderson B, Boxerman SB. Circumcision: II. Effects upon mother-infant in-teraction. Early Human Development. 1982; 7: 367–374.

[220] Morris BJ, Krieger JN. Does circumcision increase meatal stenosis risk?-A systematic review and meta-analysis. Urology. 2017; 110: 16–26.

[221] Özen MA, Gündoğdu G, Taşdemir M, Eroğlu E. Complication of newborn circumcision: meatal stenosis or meatal web? Jour-nal of Pediatric Urology. 2017; 13: 617.e1–617.e4.

[222] Salimi A, Besharati M, Rashidi Nia S, Shahmoradi S, Eftekhari SS. Application of topical hydrocortisone ointment decreases post-circumcision meatal stenosis in neonates: A cross-sectional study. International Journal of Pediatrics. 2017; 5: 5061–5067.

[223] Dubrovsky AS, Foster BJ, Jednak R, Mok E, McGillivray D. Visibility of the urethral meatus and risk of urinary tract in-fections in uncircumcised boys. Canadian Medical Association Journal. 2012; 184: E796–E803.

[224] McGregor TB, Pike JG, Leonard MP. Pathologic and physi-ologic phimosis: approach to the phimotic foreskin. Canadian Family Physician Medecin De Famille Canadien. 2007; 53: 445–448.

[225] Frisch M, Simonsen J. Ritual circumcision and risk of autism spectrum disorder in 0- to 9-year-old boys: national cohort study in Denmark. Journal of the Royal Society of Medicine. 2015; 108: 266–279.

[226] Morris BJ, Krieger JN. Re: Cultural background, non-therapeutic circumcision and the risk of meatal stenosis and other urethral stricture disease: two nationwide register-based cohort studies in Denmark 1977–2013. The Surgeon. 2018; 16: 126–129.

[227] Taddio A, Katz J, Ilersich AL, Koren G. Effect of neonatal cir-cumcision on pain response during subsequent routine vaccina-tion. Lancet. 1997; 349: 599–603.

[228] Taddio A, Pollock N, Gilbert-MacLeod C, Ohlsson K, Ko-ren G. Combined analgesia and local anesthesia to minimize pain during circumcision. Archives of Pediatrics & Adolescent Medicine. 2000; 154: 620–623.

[229] American Academy of Pediatrics and Canadian Paediatric So-ciety. Prevention and management of pain and stress in the neonate. (published corrections: Pediatrics. 2006;118(5):2231–2241 and Pediatrics. 2007;119(2):425). Pediatrics. 2000; 105: 454–461.

[230] Benini F. Topical anesthesia during circumcision in newborn infants. Journal of the American Medical Association. 1993; 270: 850–853.

[231] Taddio A, Stevens B, Craig K, Rastogi P, Ben-David S, Shen-nan A, et al. Efficacy and safety of lidocaine-prilocaine cream for pain during circumcision. The New England Journal of Medicine. 1997; 336: 1197–1201.

[232] Lander J, Brady-Fryer B, Metcalfe JB, Nazarali S, Muttitt S. Comparison of ring block, dorsal penile nerve block, and topical anesthesia for neonatal circumcision: A randomized controlled trial. Journal of the American Medical Association. 1997; 278: 2157–2162.

[233] Wang J, Zhao S, Luo L, Liu Y, Zhu Z, Li E, et al. Dorsal penile nerve block versus eutectic mixture of local anesthetics cream for pain relief in infants during circumcision: A meta-analysis. PLoS One. 2018; 13: e0203439.

[234] Brady-Fryer B, Wiebe N, Lander JA. Pain relief for neonatal circumcision. The Cochrane Database of Systematic Reviews. 2004: CD004217.

[235] Sandeman DJ, Dilley AV. Ultrasound guided dorsal penile nerve block in children. Anaesthesia and Intensive Care. 2007; 35: 266–269.

[236] Cyna AM, Middleton P. Caudal epidural block versus other methods of postoperative pain relief for circumcision in boys. The Cochrane Database of Systematic Reviews. 2008: CD003005.

[237] Sandeman DJ, Reiner D, Dilley AV, Bennett MH, Kelly KJ. A retrospective audit of three different regional anaesthetic tech-niques for circumcision in children. Anaesthesia and Intensive Care. 2010; 38: 519–524.

[238] Nguyen TT, Kraft E, Nasrawi Z, Joshi M, Merianos D. Avoid-ance of general anesthesia for circumcision in infants under 6 months of age using a modified plastibell technique. Pediatric Surgery International. 2019; 35: 619–623.

[239] Jayanthi VR, Burns JE, Koff SA. Postneonatal circumcision with local anesthesia: A cost-effective alternative. Journal of Urology. 1999; 161: 1301–1303.

[240] Weksler N, Atias I, Klein M, Rosenztsveig V, Ovadia L, Gur-man GM. Is penile block better than caudal epidural block for postcircumcision analgesia? Journal of Anesthesia. 2005; 19: 36–39.

[241] Kacker S, Frick KD, Gaydos CA, Tobian AAR. Costs and ef-fectiveness of neonatal male circumcision. Archives of Pedi-atrics & Adolescent Medicine. 2012; 166: 910–918.

[242] Andrews AL, Lazenby GB, Unal ER, Simpson KN. The cost of Medicaid savings: the potential detrimental public health im-pact of neonatal circumcision defunding. Infectious Diseases in Obstetrics and Gynecology. 2012; 2012: 540295.

[243] Ortenberg J, Roth CC. Projected financial impact of noncover-age of elective circumcision by Louisiana Medicaid in boys 0 to 5 years old. Journal of Urology. 2013; 190: 1540–1544.

[244] Gutwein LG, Alvarez JF, Gutwein JL, Kays DW, Islam S. Al-location of healthcare dollars: analysis of nonneonatal circum-cisions in Florida. The American Surgeon. 2013; 79: 865–869.

[245] Leibowitz AA, Desmond K, Belin T. Determinants and policy implications of male circumcision in the United States. Ameri-can Journal of Public Health. 2009; 99: 138–145.

[246] Morris BJ, Bailis SA, Waskett JH, Wiswell TE, Halperin DT. Medicaid coverage of newborn circumcision: A health parity right of the poor. American Journal of Public Health. 2009; 99: 969–971.

[247] Hutchinson AB, Farnham PG, Dean HD, Ekwueme DU, del Rio C, Kamimoto L, et al. The economic burden of HIV in the United States in the era of highly active antiretroviral therapy: evidence of continuing racial and ethnic differences. Journal of Acquired Immune Deficiency Syndromes. 2006; 43: 451–457.

[248] Attorneys for the Rights of the Child. June update: Florida and Norway. 2014. Available at: update-florida-and-norway (Accessed: 5 August 2021).

[249] United Nations Human Rights Office of the High Commis-sioner for Human Rights, Convention on the Rights of the Child. 44/25 20 November 1989. Available at: https://www.ohchr.or g/en/professionalinterest/pages/crc.aspx (Accesed: 6 November 2021).

[250] Cologne Regional Court. Decision of May 7, 2012, Docket No. Az. 151 Ns 169/11, Landgericht Köln Cologne. Avail-able at: s-169-11-beschneidung.pdf [English translation, Durham Uni-versity, UK: JudgmentLGCologne7May20121.pdf] (Accessed: 26 July 2016). (In German)

[251] Stafford N. German ethics council backs religious circumcision if specific conditions met. British Medical Journal. 2012; 345: e5789.

[252] California Assembly Bill 768. Male circumcision. 2011. Avail-able at: (Ac-cessed: 11 June 2021).

[253] Brady MT. Newborn male circumcision with parental consent, as stated in the AAP circumcision policy statement, is both legal and ethical. The Journal of Law, Medicine & Ethics. 2016; 44: 256–262.

[254] Morris BJ, Krieger JN, Klausner JD, Rivin BE. The ethical course is to recommend infant male circumcision — arguments disparaging American academy of pediatrics affirmative policy do not withstand scrutiny. Journal of Law, Medicine & Ethics. 2017; 45: 647–663.

[255] Rivin BE, Diekema DS, Mastroianni AC, Krieger JN, Klaus-ner JD, Morris BJ. Critical evaluation of Adler’s challenge to the cdc’s male circumcision recommendations. The International Journal of Children’s Rights. 2016; 24: 265–303.

[256] Centers for Disease Control and Prevention. Summary of Pub-lic Comments and CDC Responses to Public Comments for In-formation for Providers Counseling Male patients and Parents Regarding Male Circumcision and the Prevention of HIV In-fection, Sexually Transmitted Infections, and Other Health Out-comes. 2018. Available at: HISA-Public-Comments-and-Responses.pdf (Accessed: 25 October 2021).

[257] Bates MJ, Ziegler JB, Kennedy SE, Mindel A, Wodak AD, Zoloth LS, et al. Recommendation by a law body to ban infant male circumcision has serious worldwide implications for pedi-atric practice and human rights. BMC Pediatrics. 2013; 13: 136.

[258] Tasmanian Law Reform Institute. Non-therapeutic male circumcision. Final report no 17, 2012 (pp. 109). Available at:

n- Therapuetic-Circ_Final-Report-August-2012.pdf (Accessed: 26 October 2021).

[259] Xu B, Goldman H. Newborn circumcision in Victoria, Aus-tralia: reasons and parental attitudes. ANZ Journal of Surgery. 2008; 78: 1019–1022.

[260] Benatar M, Benatar D. Between prophylaxis and child abuse: the ethics of neonatal male circumcision. The American Journal of Bioethics. 2003; 3: 35–48.

[261] Benatar D, Benatar M. How not to argue about circumcision. American Journal of Bioethics. 2003; 3: W1–W9.

[262] Benatar D. Evaluations of circumcision should be circum-scribed by the evidence. Journal of Medical Ethics. 2013; 39: 431–432.

[263] Jacobs AJ. The ethics of circumcision of male infants. The Is-rael Medical Association Journal. 2013; 15: 60–65.

[264] Jacobs AJ, Arora KS. Ritual male infant circumcision and hu-man rights. The American Journal of Bioethics. 2015; 15: 30–39.

[265] Bester JC. Ritual male infant circumcision: the consequences and the principles say yes. The American Journal of Bioethics. 2015; 15: 56–58.

[266] Mazor J. The child’s interests and the case for the permissibility of male infant circumcision. Journal of Medical Ethics. 2013; 39: 421–428.

[267] Diekema DS. Boldt v. Boldt: A pediatric ethics perspective. The Journal of Clinical Ethics. 2009; 20: 251–257.

[268] Frisch M, Aigrain Y, Barauskas V, Bjarnason R, Boddy S, Cza-uderna P, et al. Cultural bias in the AAP’s 2012 Technical Report and Policy Statement on male circumcision. Pediatrics. 2013; 131: 796–800.

[269] Blank S, Brady M, Buerk E, Carlo W, Diekema D, Freedman A, et al. Cultural bias and circumcision: The AAP Task Force on circumcision responds. Pediatrics. 2013; 131: 801–804.

[270] Morris BJ, Tobian AAR, Hankins CA, Klausner JD, Banerjee J, Bailis SA, et al. Veracity and rhetoric in paediatric medicine: A critique of Svoboda and Van Howe’s response to the AAP policy on infant male circumcision. Journal of Medical Ethics. 2014; 40: 463–470.

[271] Morris BJ, Krieger JN, Klausner JD. CDC’s male circumcision recommendations represent a key public health measure. Global Health, Science and Practice. 2017; 5: 15–27.

[272] Frisch M, Earp BD. Circumcision of male infants and children as a public health measure in developed countries: A critical assessment of recent evidence. Global Public Health. 2018; 13: 626–641.

[273] Adler PW. The draft CDC circumcision recommendations: medical, ethical, legal, and procedural concerns. The Interna-tional Journal of Children’s Rights. 2016; 24: 239–264.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Directory of Open Access Journals (DOAJ) DOAJ is a unique and extensive index of diverse open access journals from around the world, driven by a growing community, committed to ensuring quality content is freely available online for everyone.

SCImago The SCImago Journal & Country Rank is a publicly available portal that includes the journals and country scientific indicators developed from the information contained in the Scopus® database (Elsevier B.V.)

Publication Forum - JUFO (Federation of Finnish Learned Societies) Publication Forum is a classification of publication channels created by the Finnish scientific community to support the quality assessment of academic research.

Scopus: CiteScore 0.7 (2022) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Norwegian Register for Scientific Journals, Series and Publishers Search for publication channels (journals, series and publishers) in the Norwegian Register for Scientific Journals, Series and Publishers to see if they are considered as scientific. (

Submission Turnaround Time